The Technical University of Munich Cancer Center - elevating cancer treatment through science No … ← Prognostic role of pre-diagnostic circulating inflammatory biomarkers in breast cancer survival: evidence from the EPIC cohort study CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients →